Skip to main content
Premium Trial:

Request an Annual Quote

Modell Foundation Pumps $1M into Primary Immunodeficiency Projects

NEW YORK (GenomeWeb) – The Jeffrey Modell Foundation said today it has provided $1 million to fund five research projects developing methods for diagnosing and treating genetic immune deficiency diseases, or primary immunodeficiencies (PIs).

The foundation is not able to disclose the winners of the Translational Research Program grants at this time due to reasons of confidentiality, a spokesperson for JMF told GenomeWeb Daily News in an e-mail.

The foundation said, however, that the winners include teams based in Boston, Washington, DC, France, Israel, and Italy. The winners were selected from a group of 42 applications the foundation received from 15 countries.

The foundation created the program to back research that will advance knowledge of and treatments, diagnostics, and cures for PIs. Specifically, the program aims to enhance knowledge of genotype-phenotype correlations and the mechanisms that underlie immune function and dysfunction. According to the foundation's website, the translational grants will provide up to $250,000 over a two-year period to each award winner.

PI affects as many as 10 million people worldwide, although most patients are undiagnosed and untreated, JMF said.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.